Detalhe da pesquisa
1.
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 596(7870): 126-132, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290408
2.
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 598(7881): E1, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608287
3.
Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types.
Int J Cancer
; 145(12): 3425-3435, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31373686
4.
Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment.
J Neurooncol
; 143(2): 241-249, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025274
5.
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma.
Int J Cancer
; 143(12): 3201-3208, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30248181
6.
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.
Nat Med
; 30(4): 1023-1034, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504015
7.
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer.
Clin Cancer Res
; 29(12): 2310-2323, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071497
8.
Persistent mutation burden drives sustained anti-tumor immune responses.
Nat Med
; 29(2): 440-449, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702947
9.
The role of STAT3 activation in modulating the immune microenvironment of GBM.
J Neurooncol
; 110(3): 359-68, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23096132
10.
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
J Neurosurg
; 136(2): 379-388, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388730
11.
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688557
12.
Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.
Clin Dev Immunol
; 2011: 732413, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22190972
13.
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.
Nat Med
; 27(11): 1910-1920, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750557
14.
Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy.
Neurooncol Adv
; 2(1): vdaa011, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32642679
15.
In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation.
Int J Radiat Oncol Biol Phys
; 106(3): 612-620, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738948
16.
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma.
Cell Rep Med
; 1(8): 100139, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33294860
17.
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.
Nat Cancer
; 1(1): 99-111, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984843
18.
PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors.
Cureus
; 11(12): e6352, 2019 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31938638
19.
Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.
Oncotarget
; 9(29): 20681-20697, 2018 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755681
20.
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.
Oncoimmunology
; 7(8): e1466769, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30221069